Clinical trial · Interventional
Lidocaine And Neuromonitoring in Thyroid Surgery
Intravenous Or Topical Lidocaine And Neuromonitoring in Thyroid Surgery (IOLANT Study)
NCT04574947CI-TRIAL-00075274completedPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to test the hypothesis that the quality of recovery with topical lidocaine is better than placebo.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Anesthesia | — | UNRESOLVED | — |
| Parathyroid Neoplasms | Parathyroid Gland Neoplasm | ALIAS | 0.90 |
| Thyroid Neoplasm | Thyroid Gland Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Intra-cuff lidocaine | Procedure | — | UNRESOLVED |
| Intra-cuff placebo | Procedure | — | UNRESOLVED |
| Intravenous lidocaine | Drug | — | UNRESOLVED |
| Intravenous placebo | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- ACTIVE_COMPARATOR
- label
- Intravenous lidocaine
- interventionNames
- Drug: Intravenous lidocaine
- Procedure: Intra-cuff placebo
- type
- EXPERIMENTAL
- label
- Topical lidocaine
- interventionNames
- Drug: Intravenous placebo
- Procedure: Intra-cuff lidocaine
- type
- PLACEBO_COMPARATOR
- label
- Placebo
- interventionNames
- Drug: Intravenous placebo
- Procedure: Intra-cuff placebo
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 45 Years
Show eligibility criteria text
Inclusion Criteria: * Planned thyroid surgery * Age\> 45 years * Signed informed consent to participate in the study Exclusion Criteria: * Emergency surgery * Redo surgery * Contraindications for lidocaine use * Pregnancy * Enrolment to another randomised clinical trial within the last 30 days
References
Publications (0)
Data not yet available
No reference posted for this study.